JMVNX
Price
$14.58
Change
-$0.25 (-1.69%)
Updated
Jun 13 closing price
Net Assets
1.33B
MVCAX
Price
$30.04
Change
-$0.44 (-1.44%)
Updated
Jun 13 closing price
Net Assets
16.82B
Interact to see
Advertisement

JMVNX vs MVCAX

Header iconJMVNX vs MVCAX Comparison
Open Charts JMVNX vs MVCAXBanner chart's image
JHFunds2 Mid Value NAV
Price$14.58
Change-$0.25 (-1.69%)
VolumeN/A
Net Assets1.33B
MFS Mid Cap Value A
Price$30.04
Change-$0.44 (-1.44%)
VolumeN/A
Net Assets16.82B
JMVNX vs MVCAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JMVNX vs. MVCAX commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMVNX is a Hold and MVCAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 16.8B vs. JMVNX (1.33B). JMVNX pays higher dividends than MVCAX: JMVNX (1.30) vs MVCAX (0.89). JMVNX was incepted earlier than MVCAX: JMVNX (16 years) vs MVCAX (24 years). MVCAX (1.00) and JMVNX (0.96) have similar cost to investors . JMVNX is a more actively managed with annual turnover of: 46.00 vs. MVCAX (27.00). JMVNX has a lower initial minimum investment than MVCAX: JMVNX (0) vs MVCAX (1000). MVCAX annual gain was more profitable for investors over the last year : -4.53 vs. JMVNX (-14.75). MVCAX return over 5 years is better than : 51.98 vs. JMVNX (14.74).
JMVNXMVCAXJMVNX / MVCAX
Total Expense Ratio0.950.9996%
Annual Report Gross Expense Ratio0.961.0096%
Fund Existence16 years24 years-
Gain YTD-4.268-2.086205%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.33B16.8B8%
Annual Yield % from dividends1.300.89145%
Returns for 1 year-14.75-4.53325%
Returns for 3 years-11.4013.00-88%
Returns for 5 years14.7451.9828%
Returns for 10 years-3.1453.51-6%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLTX44.210.19
+0.43%
MoonLake Immunotherapeutics
RYI20.78-0.47
-2.21%
RYERSON HOLDING Corp
SWK65.26-2.16
-3.20%
Stanley Black & Decker
NMRA0.84-0.05
-5.94%
Neumora Therapeutics
DWTX4.65-0.53
-10.23%
Dogwood Therapeutics Inc